We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Interim Analysis Suggests Novavax's COVID-19 Vaccine Has 89.3% Efficacy Rate

News   Jan 29, 2021

 
Interim Analysis Suggests Novavax's COVID-19 Vaccine Has 89.3% Efficacy Rate

Credit: torstensimon from Pixabay.

 
 
Advertisement
 

RELATED ARTICLES

Cytokine Effects Set SARS-CoV-2 Apart From Other Respiratory Viruses

News

Analyzing cytokine responses from patients infected with SARS-CoV-2 and similar common respiratory viruses has unearthed glaringly important differences in how SARS-CoV-2 affects cytokines compared to other common respiratory viruses.

READ MORE

How Cells Use Molecular Motors To Avoid Bright Light

News

Researchers have discovered a new component of molecular motors that drives cellular movement in response to light.

READ MORE

Swapping Alpha Cells for Beta Cells To Treat Diabetes

News

Blocking cell receptors for glucagon, the counter-hormone to insulin, cured mouse models of diabetes by converting glucagon-producing cells into insulin producers instead.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE